Navigation Links
John H. Landon Joins LipoScience Board of Directors
Date:12/3/2007

RALEIGH, N.C., Dec. 3 /PRNewswire/ -- LipoScience, Inc. is pleased to announce the election of John H. Landon to its Board of Directors.

Mr. Landon has over 30 years of broad, multi-functional experience with the DuPont Company. Prior to retiring from active management, Mr. Landon was Vice President & General Manager of Medical Products for DuPont. He had worldwide, full functional responsibility for all of DuPont's Medical Products businesses, with total sales of $1 billion and over 5,000 employees.

Mr. Landon recently served as Chairman of the Board of Cholestech Corporation and Director of Digene Corporation. He currently is a member of the board for Christiana Care Health System and a member of the Board of Advisors for Water Street Healthcare Partners.

"John's extensive leadership and board experience in the in vitro diagnostic industry will make a major contribution to our board," said Dr. Charles A. Sanders, Chairman of the Board. "He will bring invaluable expertise to LipoScience as we establish the NMR LipoProfile(R) test as a clinical standard of care," Sanders added.

About LipoScience, Inc.:

LipoScience, Inc. markets the NMR LipoProfile(R) test to clinicians, commercial diagnostic laboratories and clinical research clients. Founded in 1994, LipoScience introduced the NMR LipoProfile blood test for clinical research in 1997 and for use in patient care in 1999.


'/>"/>
SOURCE LipoScience, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Richard Greco Joins Mediware Board
2. Johnson & Johnson Campaign for Nursings Future Joins With AACN to Offer New Minority Nurse Faculty Scholars Program
3. Sean P. McLaughlin Joins Red Cross as Chief of Operations Support
4. Dr. Mahesh Ramachandran Joins Marianjoy Medical Group
5. Nick Childs Joins Grey New York as Director of Content Development
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. David Ward Joins OrthoSynetics(TM) as Western Region Sales Manager
8. NASN Joins Partnership to Fight Chronic Disease
9. AstraZeneca Joins Local Walking Movement
10. Proxy Governance Joins ISS, Glass Lewis and Egan Jones in Recommending Arrow International Shareholders Vote to Approve the $45.50 Per Share Merger With Teleflex
11. Fund Manager Joins Board of GSI Securitization Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/26/2016)... ... , ... Quality metrics are proliferating in cancer care, and are derived from ... of the beholder, according to experts who offered insights and commentary in the current ... For the full issue, click here . , For the American Society of ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , ... Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , ... our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... people are unfamiliar with. The article goes on to state that individuals are now ... of these less common operations such as calf and cheek reduction. The Los Angeles ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with ... Latin America . ... ... ... ...
Breaking Medicine Technology: